Vigilant Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.86M Sell
3,976
-250
-6% -$105K 0.14% 51
2023
Q1
$1.45M Buy
4,226
+71
+2% +$23.9K 0.12% 52
2022
Q4
$1.52M Buy
4,155
+143
+4% +$50.7K 0.13% 53
2022
Q3
$1.3M Buy
4,012
+81
+2% +$25.7K 0.12% 52
2022
Q2
$1.27M Buy
3,931
+141
+4% +$42.3K 0.11% 54
2022
Q1
$1.08M Sell
3,790
-200
-5% -$51.5K 0.08% 61
2021
Q4
$1.1M Hold
3,990
0.08% 64
2021
Q3
$922K Sell
3,990
-543
-12% -$134K 0.07% 62
2021
Q2
$1.04M Buy
4,533
+94
+2% +$18.9K 0.08% 62
2021
Q1
$829K Hold
4,439
0.07% 63
2020
Q4
$749K Buy
4,439
+474
+12% +$70.8K 0.07% 62
2020
Q3
$587K Hold
3,965
0.06% 67
2020
Q2
$651K Hold
3,965
0.08% 60
2020
Q1
$550K Sell
3,965
-262
-6% -$36K 0.08% 61
2019
Q4
$556K Hold
4,227
0.06% 72
2019
Q3
$473K Hold
4,227
0.06% 72
2019
Q2
$468K Hold
4,227
0.06% 74
2019
Q1
$548K Sell
4,227
-735
-15% -$89.4K 0.08% 75
2018
Q4
$574K Sell
4,962
-10,683
-68% -$1.19M 0.09% 72
2018
Q3
$1.68M Sell
15,645
-494
-3% -$49.4K 0.22% 54
2018
Q2
$1.38M Hold
16,139
0.2% 54
2018
Q1
$1.25M Hold
16,139
0.18% 61
2017
Q4
$1.36M Buy
+16,139
New +$1.37M 0.18% 70

Other funds holding LLY

Vigilant Capital Management's LLY Position: Q2 2023 in Review

Vigilant Capital Management reduced its Eli Lilly (LLY) stake by 5.9% in Q2 2023, selling an estimated $105K and leaving 3,976 shares worth $1.86M. The position accounts for 0.14% of the portfolio, ranked #51.

Vigilant Capital Management first reported a position in LLY in Q4 2017 and has held it in 23 quarters since. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Vigilant Capital Management held 3,976 shares of Eli Lilly worth $1.86M as of Q2 2023.
  • Vigilant Capital Management sold 250 Eli Lilly shares in Q2 2023, an estimated $105K.
  • Eli Lilly made up 0.14% of Vigilant Capital Management's portfolio in Q2 2023, its #51 holding.
  • Vigilant Capital Management first reported a position in Eli Lilly in Q4 2017 and has held it in 23 quarters since.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.